Skip to content
healthcare.dev

Guaifenesin and Pseudoephedrine Hydrochloride

NDC 62011-0475, Guaifenesin and Pseudoephedrine Hydrochloride, tablet, extended release, from STRATEGIC SOURCING SERVICES LLC.

Product NDC
62011-0475
Status
Listed
Labeler
STRATEGIC SOURCING SERVICES LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA212542
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62011-0475 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN600 mg/1
  • PSEUDOEPHEDRINE HYDROCHLORIDE60 mg/1

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; alpha-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
62011-0475-1620110475011 BLISTER PACK in 1 CARTON (62011-0475-1) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 62011-0475 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62011-0475 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62011-0475. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.